These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 1502985

  • 1. [Ciliary body changes associate with aldose reductase in galactosemic rats (2)].
    Ikebe H, Terubayashi H, Okamoto S, Matsumoto Y, Tsutsumi M, Ibaraki N, Akagi Y.
    Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):860-4. PubMed ID: 1502985
    [Abstract] [Full Text] [Related]

  • 2. [Ciliary body changes associate with aldose reductase in galactosemic rats].
    Ikebe H, Terubayashi H, Akagi Y, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1989 Jul; 93(7):758-62. PubMed ID: 2514592
    [Abstract] [Full Text] [Related]

  • 3. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ, Harris R, Brightman A, McGill J, Hua D, Davidson H, Fenwick B, Wagner LM.
    Vet Ophthalmol; 2004 Jul; 7(3):163-7. PubMed ID: 15091323
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB, Kador PF, Kashima K, Kinoshita JH, Sinha A.
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [Abstract] [Full Text] [Related]

  • 7. [The role of aldose reductase in diabetic corneal epitheliopathy. Second report: The corneal epithelium of galactosemic rats].
    Takahashi Y, Akagi Y, Akimune M, Tamura K, Itoi M.
    Nippon Ganka Gakkai Zasshi; 1986 Feb; 90(2):336-40. PubMed ID: 3085442
    [No Abstract] [Full Text] [Related]

  • 8. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA.
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
    Lewis S, Karrer J, Saleh S, Chan X, Tan Z, Hua D, McGill J, Pang YP, Fenwick B, Brightman A, Takemoto D.
    Mol Vis; 2001 Jul 18; 7():164-71. PubMed ID: 11483892
    [Abstract] [Full Text] [Related]

  • 10. [Preventional and therapeutic effects of aldose reductase inhibitor FR74366 on rat galactose cataract].
    Tsuji T, Matsumoto Y, Mori K, Ikebe H, Terubayashi H, Akagi Y, Tanimoto T.
    Nippon Ganka Gakkai Zasshi; 1990 Feb 18; 94(2):120-7. PubMed ID: 2114732
    [Abstract] [Full Text] [Related]

  • 11. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
    Terubayashi H, Akagi Y.
    Jpn J Ophthalmol; 1989 Feb 18; 33(3):343-7. PubMed ID: 2507812
    [Abstract] [Full Text] [Related]

  • 12. Effect of aldose reductase inhibitor on corneal epithelial barrier function in galactose-fed dogs.
    Kubo E, Mori K, Kobayashi T, Takahashi Y, Yokoi N, Kinoshita S, Kasahara T, Yonezawa H, Akagi Y.
    J Ocul Pharmacol Ther; 1998 Apr 18; 14(2):181-90. PubMed ID: 9572544
    [Abstract] [Full Text] [Related]

  • 13. Minalrestat, an aldose reductase inhibitor, corrects the impaired microvascular reactivity in diabetes.
    Akamine EH, Hohman TC, Nigro D, Carvalho MH, de Cássia Tostes R, Fortes ZB.
    J Pharmacol Exp Ther; 2003 Mar 18; 304(3):1236-42. PubMed ID: 12604701
    [Abstract] [Full Text] [Related]

  • 14. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S, Kikuchi C, Ono T, Notsu Y.
    Invest Ophthalmol Vis Sci; 1991 Nov 18; 32(12):3078-83. PubMed ID: 1834606
    [Abstract] [Full Text] [Related]

  • 15. Galactosemic neuropathy in transgenic mice for human aldose reductase.
    Yagihashi S, Yamagishi S, Wada R, Sugimoto K, Baba M, Wong HG, Fujimoto J, Nishimura C, Kokai Y.
    Diabetes; 1996 Jan 18; 45(1):56-9. PubMed ID: 8522060
    [Abstract] [Full Text] [Related]

  • 16. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS, Ghosh MN.
    Indian J Physiol Pharmacol; 1981 Jan 18; 25(3):193-200. PubMed ID: 6795119
    [No Abstract] [Full Text] [Related]

  • 17. [The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract].
    Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Akagi Y.
    Nippon Ganka Gakkai Zasshi; 2003 Oct 18; 107(10):565-70. PubMed ID: 14598706
    [Abstract] [Full Text] [Related]

  • 18. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M, Fukui H, Kuwabara T, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1982 Feb 18; 22(2):174-9. PubMed ID: 6799419
    [Abstract] [Full Text] [Related]

  • 19. [Prefeeding of aldose reductase inhibitor inhibits galactose cataract].
    Tsuji T, Okamoto S, Ikebe H, Terubayashi H, Akagi Y, Tanimoto T.
    Nippon Ganka Gakkai Zasshi; 1993 Apr 18; 97(4):455-9. PubMed ID: 8317365
    [Abstract] [Full Text] [Related]

  • 20. Galactose-induced retinal microangiopathy in rats.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1995 Feb 18; 36(2):490-6. PubMed ID: 7843917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.